Anti-Müllerian Hormone Based Protocol Versus The Traditional Protocol For in-Vitro Fertilization/ Intracytoplasmic Sperm Injection: A Randomized Controlled Trial
{"title":"Anti-Müllerian Hormone Based Protocol Versus The Traditional Protocol For in-Vitro Fertilization/ Intracytoplasmic Sperm Injection: A Randomized Controlled Trial","authors":"A. Mahran","doi":"10.21608/EBWHJ.2017.3279","DOIUrl":null,"url":null,"abstract":"Objectives: To compare the AMH based protocol and the traditional protocol in patients undergoing IVF/ICSI.Study Design: Randomized controlled trial. Patients and Methods: Two hundred patients candidate for IVF/ICSI were randomized intro two group; AMH-basedprotocol group (n = 100) and traditional protocol group (n = 100).Results: There two groups were similar as regards the demographic features and baseline hormones. The antagonistprotocol was used more frequently in the AMH group compared to the traditional protocol group (62% vs. 19%, P = 0.03).The duration of stimulation was shorter and the total dose of gonadotropins was lower in the AMH group (10.2 ± 2.8 vs.11.7 ± 2.7, P = 0.05 and 2133.4 ± 432.5 vs. 2875.4 ± 465.7, P = 0.04, respectively). The clinical pregnancy rate (CPR)and live birth rate were higher in the AMH group compared to the control group (49.5% vs.30.7%, P = 0.001 and 43.3%vs.23.9%, P =0.001 respectively). In the AMH group, two cases were cancelled due to poor response and one case wascancelled due to moderate ovarian hyperstimulation syndrome (OHSS) with freeze all embryos, while in the traditionalprotocol group, five cases were cancelled due to poor response and seven cases were cancelled due to moderate / severeOHSS (2% vs. 5%, P =0.002 and 1% vs. 7%, P = 0.001 respectively).Conclusion: AMH based protocol was significantly associated with improvement of CPR and live birth rate whilereducing the adverse outcomes such as OHSS and cycle cancellation rate in patients undergoing IVF/ICSI.","PeriodicalId":224226,"journal":{"name":"Evidence Based Womenʼs Health Journal","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2017-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Evidence Based Womenʼs Health Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/EBWHJ.2017.3279","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: To compare the AMH based protocol and the traditional protocol in patients undergoing IVF/ICSI.Study Design: Randomized controlled trial. Patients and Methods: Two hundred patients candidate for IVF/ICSI were randomized intro two group; AMH-basedprotocol group (n = 100) and traditional protocol group (n = 100).Results: There two groups were similar as regards the demographic features and baseline hormones. The antagonistprotocol was used more frequently in the AMH group compared to the traditional protocol group (62% vs. 19%, P = 0.03).The duration of stimulation was shorter and the total dose of gonadotropins was lower in the AMH group (10.2 ± 2.8 vs.11.7 ± 2.7, P = 0.05 and 2133.4 ± 432.5 vs. 2875.4 ± 465.7, P = 0.04, respectively). The clinical pregnancy rate (CPR)and live birth rate were higher in the AMH group compared to the control group (49.5% vs.30.7%, P = 0.001 and 43.3%vs.23.9%, P =0.001 respectively). In the AMH group, two cases were cancelled due to poor response and one case wascancelled due to moderate ovarian hyperstimulation syndrome (OHSS) with freeze all embryos, while in the traditionalprotocol group, five cases were cancelled due to poor response and seven cases were cancelled due to moderate / severeOHSS (2% vs. 5%, P =0.002 and 1% vs. 7%, P = 0.001 respectively).Conclusion: AMH based protocol was significantly associated with improvement of CPR and live birth rate whilereducing the adverse outcomes such as OHSS and cycle cancellation rate in patients undergoing IVF/ICSI.